Vesicular Stomatitis Virus: From Agricultural Pathogen to Vaccine Vector

Vesicular Stomatitis Virus: From Agricultural Pathogen to Vaccine Vector

Vesicular stomatitis virus (VSV), which belongs to the <i>Vesiculovirus</i> genus of the family <i>Rhabdoviridae</i>, is a well studied livestock pathogen and prototypic non-segmented, negative-sense RNA virus. Although VSV is responsible for causing economically significant...

Full description

Bibliographic Details
Main Authors:	Guodong Liu, Wenguang Cao, Abdjeleel Salawudeen, Wenjun Zhu, Karla Emeterio, David Safronetz, Logan Banadyga
Format:	Article
Language:	English
Published:	MDPI AG 2021-08-01
Series:	Pathogens
Subjects:	vesicular stomatitis virus VSV vaccine countermeasure Ebola virus VSV-EBOV
Online Access:	https://www.mdpi.com/2076-0817/10/9/1092

Similar Items

Safety of Recombinant VSV–Ebola Virus Vaccine Vector in Pigs
by: Emmie de Wit, et al.
Published: (2015-04-01)

A Cloned Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine, PHV01, Protects Guinea Pigs from Lethal Marburg Virus Disease
by: Wenjun Zhu, et al.
Published: (2022-06-01)

Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens
by: Anahita Fathi, et al.
Published: (2019-10-01)

Untargeted Lipidomics of Vesicular Stomatitis Virus-Infected Cells and Viral Particles
by: Katherine E. Havranek, et al.
Published: (2021-12-01)

The Methyltransferase Region of Vesicular Stomatitis Virus L Polymerase Is a Target Site for Functional Intramolecular Insertion
by: Emmanuel Heilmann, et al.
Published: (2019-10-01)

Effect of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Vaccination on Ebola Virus Disease Illness and Death, Democratic Republic of the Congo
by: Neil Rupani, et al.
Published: (2022-06-01)

Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy
by: Suman Bishnoi, et al.
Published: (2018-02-01)

Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses
by: Andrea Marzi, et al.
Published: (2015-02-01)

Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection
by: Andrea R. Menicucci, et al.
Published: (2019-06-01)

Tamoxifen Protects from Vesicular Stomatitis Virus Infection
by: Lamin B. Cham, et al.
Published: (2019-09-01)

Closer than ever to an Ebola virus vaccine
by: Logan Banadyga, et al.
Published: (2017-05-01)

Ebola Virus Glycoprotein Domains Associated with Protective Efficacy
by: Bharti Bhatia, et al.
Published: (2021-06-01)

To B or Not to B: Mechanisms of Protection Conferred by rVSV-EBOV-GP and the Roles of Innate and Adaptive Immunity
by: Amanda N. Pinski, et al.
Published: (2020-09-01)

Vesicular stomatitis Indiana virus near-full-length genome sequences reveal low genetic diversity during the 2019 outbreak in Colorado, USA
by: Miranda R. Bertram, et al.
Published: (2023-02-01)

Efficient Production of Human Norovirus-Specific IgY in Egg Yolks by Vaccination of Hens with a Recombinant Vesicular Stomatitis Virus Expressing VP1 Protein
by: Yang Zhu, et al.
Published: (2019-05-01)

High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission
by: Igor Morozov, et al.
Published: (2021-01-01)

Vesicular Stomatitis Virus Elicits Early Transcriptome Response in <i>Culicoides sonorensis</i> Cells
by: Stacey L. P. Scroggs, et al.
Published: (2023-10-01)

The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma
by: Janine Kimpel, et al.
Published: (2018-03-01)

Detection of buffaloes (Bubalus bubalis) seroreactive for vesicular stomatitis virus in the state of Paraíba, Northeastern Brazil
by: Camila de Sousa Bezerra, et al.
Published: (2019-10-01)

Detection of Vesicular Stomatitis Virus Indiana from Insects Collected during the 2020 Outbreak in Kansas, USA
by: Bethany L. McGregor, et al.
Published: (2021-09-01)

Cytopathogenesis of Vesicular Stomatitis Virus Is Regulated by the PSAP Motif of M Protein in a Species-Dependent Manner
by: Ronald N. Harty, et al.
Published: (2012-09-01)

<i>Culicoides</i>-Specific Fitness Increase of Vesicular Stomatitis Virus in Insect-to-Insect Infections
by: Paula Rozo-Lopez, et al.
Published: (2024-01-01)

Preclinical efficacy of oncolytic VSV-IFNβ in treating cancer: A systematic review
by: Abdulaziz Molham Moglan, et al.
Published: (2023-03-01)

Prediction and validation of murine MHC class I epitopes of the recombinant virus VSV-GP
by: Saskia V. Vijver, et al.
Published: (2023-01-01)

Trap and ambush therapy using sequential primary and tumor escape-selective oncolytic viruses
by: Mason J. Webb, et al.
Published: (2023-06-01)

Oral Immunization with rVSV Bivalent Vaccine Elicits Protective Immune Responses, Including ADCC, against Both SARS-CoV-2 and Influenza A Viruses
by: Maggie Jing Ouyang, et al.
Published: (2023-08-01)

Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells
by: Hua-Long Xiong, et al.
Published: (2020-01-01)

Induction of Tier 1 HIV Neutralizing Antibodies by Envelope Trimers Incorporated into a Replication Competent Vesicular Stomatitis Virus Vector
by: C. Anika Bresk, et al.
Published: (2019-02-01)

Development of Recombinant Oncolytic rVSV-mIL12-mGMCSF for Cancer Immunotherapy
by: Anastasia Ryapolova, et al.
Published: (2023-12-01)

Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating Immunoglobulins
by: Till Koch, et al.
Published: (2020-08-01)

Establishment of Replication Deficient Vesicular Stomatitis Virus for Studies of PEDV Spike-Mediated Cell Entry and Its Inhibition
by: Huaye Luo, et al.
Published: (2023-08-01)

Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV
by: Hiva Azizi, et al.
Published: (2023-05-01)

The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials
by: Ellen Suder, et al.
Published: (2018-09-01)

Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease
by: Thomas P. Monath, et al.
Published: (2023-09-01)

Assessment of the ability of V920 recombinant vesicular stomatitis-Zaire ebolavirus vaccine to replicate in relevant arthropod cell cultures and vector species
by: Nicholas A. Bergren, et al.
Published: (2018-04-01)

Environmental Risk Assessment for rVSVΔG-ZEBOV-GP, a Genetically Modified Live Vaccine for Ebola Virus Disease
by: Joan G. Tell, et al.
Published: (2020-12-01)

Soluble expression, protein purification and quality control of recombinant porcine interferon-α
by: Jun ZHAO, et al.
Published: (2017-05-01)

Safety and immunogenicity of intramuscular, single-dose V590 (rVSV-SARS-CoV-2 Vaccine) in healthy adults: Results from a phase 1 randomised, double-blind, placebo-controlled, dose-ranging trial
by: Jonathan A. Robbins, et al.
Published: (2022-08-01)

Progress in Elucidating Potential Markers and Mechanisms of Rapid Protection Conferred by the VSV-Vectored Ebola Virus Vaccine
by: Gary Wong
Published: (2019-08-01)

Production of Vesicular Stomatitis Virus Glycoprotein-Pseudotyped Lentiviral Vector Is Enhanced by Ezrin Silencing
by: Mai Izumida, et al.
Published: (2020-04-01)